ENTA - Enanta Pharma Q1 2020 Earnings Preview

February, 05 2020 05:35 PM Enanta Pharmaceuticals Inc.

Enanta Pharma (NASDAQ:ENTA) is scheduled to announce Q1 earnings results on Thursday, February 6th, after market close.
The consensus EPS Estimate is $0.60 (-52.0% Y/Y) and the consensus Revenue Estimate is $58.75M (-15.9% Y/Y).
Over the last 2 years, ENTA has beaten EPS estimates 50% of the time and has beaten revenue estimates 38% of the time.
Over the last 3 months, EPS estimates have seen 1 upward revision and 2 downward. Revenue estimates have seen 0 upward revisions and 2 downward.
More news on: Enanta Pharmaceuticals, Inc., Earnings news and commentary, , Healthcare stocks news,